US › Healthcare

Smith & Nephew SNATS Inc (SNN)

US · Healthcare · Medical Devices

$27.78-0.07%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$3.10B

Revenue YoY

+9.6%

Net profit

$303.0M

Profit YoY

+41.6%

EPS

$0.00

EPS estimate

$0.00

Net margin

9.8%

Key statistics

Market cap

$11.89B

P/E

19.3

Forward P/E

11.2

P/B

2.22

Book value

$2.43

EPS (TTM)

$1.47

Dividend yield

2.80%

52-week high

$36.95

52-week low

$27.23

50-day MA

$29.92

200-day MA

$31.90

Beta

0.68

Analyst view

Analysts rate Smith & Nephew SNATS Inc a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $32.89.

Shareholding

Insiders

0.01%

Institutions

11.49%

Largest institutional holders

Fund	Stake
River Road Asset Management, LLC	0.76%
The Goldman Sachs Group Inc	0.58%
BMO Capital Markets Corp.	0.53%
Brandes Investment Partners & Co	0.51%
Dimensional Fund Advisors, Inc.	0.43%
LMR Partners LLP	0.42%
Todd Asset Management	0.33%
Morgan Stanley - Brokerage Accounts	0.33%

Corporate actions

Action	Detail	Date
Dividend	$0.31 / share ex-date Oct 2, 2026 · pay Nov 6, 2026	2026-10-02
Dividend	$0.48 / share ex-date Mar 27, 2026 · pay May 27, 2026	2026-03-27
Dividend	$0.30 / share ex-date Oct 3, 2025 · pay Nov 7, 2025	2025-10-03

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Smith & Nephew SNATS Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.